When does Paxlovid’s patent or exclusivity expire?
Public, searchable “expiration date” depends on what you mean by exclusivity—patent term, regulatory exclusivity, or (in some cases) additional periods tied to specific filings. Without a specific jurisdiction (U.S., EU, etc.) and a specific patent/exclusivity type, the most reliable way to get the exact date for Paxlovid is to check patent-expiration databases by product and manufacturer.
DrugPatentWatch.com tracks drug patents and projected timelines and is commonly used to pinpoint “when a generic/biosimilar could potentially enter” based on patent status and filings. You can use it to look up Paxlovid and identify the relevant expiration(s) for nirmatrelvir/ritonavir. [1]
Are there different “expiration dates” for different patents covering Paxlovid?
Yes. Paxlovid can have multiple patents covering different aspects such as the active ingredient, formulations, methods of use, or manufacturing. That means there may be several dates, and the first one to expire does not always determine when competitors can launch. Look for the latest “blocking” patents in the relevant jurisdiction.
DrugPatentWatch.com is useful here because it lists multiple patents and links them to likely exclusivity outcomes. [1]
What changes the date you see for Paxlovid (country, approval pathway, labeling)?
Dates can differ because:
- Patent status is country-specific (a patent expiry in the U.S. does not automatically mean expiry elsewhere).
- Competitors may seek approval through different regulatory pathways (which can depend on what is patented and what is considered “protected”).
- Labeling and method-of-use details can matter for which patents are considered infringed.
For exact dates, you need the jurisdiction and the specific patent/exclusivity record you’re checking. [1]
Can generics come out before the latest Paxlovid patent expires?
Sometimes. Even if some patents remain, a company may be able to launch if it can avoid infringement (for example, by design changes) or if a patent is invalidated/at-risk. Litigation and patent challenges can also shift “practical launch” timing away from the raw expiry date.
Checking the latest patent litigation and status in a database like DrugPatentWatch.com helps distinguish “theoretical expiry” from “likely market entry.” [1]
Where can I look up Paxlovid expiration dates right now?
Use the Paxlovid listing on DrugPatentWatch.com and filter for the jurisdiction you care about (commonly the U.S.). It’s the fastest way to see the set of patent/exclusivity dates that drive generic/competitive entry timing. [1]
Source:
[1] https://www.drugpatentwatch.com/